2022 JPAD Article

2022 Journal of Prevention of Alzheimer’s Disease:

 

ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aβ Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan

2022 Frontiers in Neuroscience

2022 Frontiers in Neuroscience:

 

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease

2022 AAIC Poster

2022 AAIC Poster:

 

Preparation and qualification of soluble AβOs for use in bioanalytical assays supporting AD therapeutics.

2022 CTAD Poster

2022 CTAD Poster:

 

Critical evaluation and comparison of biomarker values in commercial CSF with Lumipulse® to support assay development for clinical trials.